Relay Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
RLAY
CUSIP
75943R102
Type
Equity
Class
COM
Num filings
271
Total reported value, excl. options
$4.75 B
Manager Report Date Value ($000) Shares Option Type